Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
Abstract

Volume 16, Issue 2 (March 2014) 16, 270–273; 10.4103/1008-682X.122343

More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not?

Hong-Jun Li

Urological Department of the Peking Union Medical
College Hospital (PUMCH), Peking Union Medical
College, Chinese Academy of Medical Sciences,
Beijing, China.

Correspondence: Correspondence: Prof. HJ Li

07 January 2014

Abstract

'Testosterone replacement is strictly
contraindicated for the treatment
of male infertility’ was the advanced view
from the ‘2013 European Association of
Urology (EAU) guidelines on male infertility’,
and this view brings extensive concern and
questions. Although sufficient numbers
of well-performed and controlled clinical
trials that provide evidence supporting
drug treatment of male infertility are not
available at present, the opportunity to
prove that these drugs are eff ective should
not be prevented, and rigorous examination
of drug therapy should be encouraged and
strengthened. Th erefore, I believe the above
conclusion in the EAU guidelines is poorly
conceived.

Full Text | PDF | 中文摘要 |

 
Browse:  3443
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.